logo
15:54 Feb 25

Albert David Ltd.

Sector Pharmaceuticals & Biotechnology Industry Pharmaceuticals
Up
713.55
+3.05 (+0.43%)
Sector Pharmaceuticals & Biotechnology Industry Pharmaceuticals

Albert David Ltd. Financials

Albert David Ltd.
Sector Pharmaceuticals & Biotechnology
Industry Pharmaceuticals
Up
713.55
+3.05 (+0.43%)
15:54 Feb 25
Quality
image/svg+xml

36/100
Medium Financial Strength

Valuation
image/svg+xml

35/100
Mid Valuation

Technical

46/100
Technically Neutral

Strength

7

Weakness

7

Opportunity

0

Threats

0

4.38 %

ROE %

3.36 %

ROA %

16.84

EPS

687.70

BVPS

0.00 %

Net Profit Margin

Mar 2021 Mar 2022 Mar 2023 Mar 2024 Mar 2025
Net Sales
247.45 313.51 341.56 362.46 345.77
Operating Expenses +
228.31 272.72 297.22 315.58 342.74
Raw Material
82.87 112.56 127.69 128.17 130.61
Increase Decrease in Cost
3.3 2.38 -4.6 -1.77 -14.33
Other Manufacturing Expense
0 0 0 0 0
Employee Cost
82.7 85.38 81.07 88.43 109.02
Miscellaneous Expenses
151.68 194.6 221.36 229.25 238.36
Operating Profit
19.14 40.79 44.34 46.88 3.03
Other Income
17.18 15.84 15.4 57.55 29.58
Depreciation
8.23 8.81 8.55 6.83 6.97
Interest
0.65 0.53 0.46 0.32 0.41
Profit before tax and exceptio..
27.44 47.3 50.74 97.29 25.23
Exceptional Items
0 0 0 0 0
PBT
27.44 47.3 50.74 97.29 25.23
Provision for Taxation
5.3 12.04 14.56 21.87 8.03
Net Profit
22.14 35.26 36.17 75.42 17.2
NET Profit after MI
0 0 0 0 0
EPS
38.8 61.78 63.39 132.15 30.14
Operating Profit Margin (%)
7.73 13.01 12.98 12.93 0.88
Net Profit Margin (%)
8.95 11.25 10.59 20.81 4.97

Albert David Ltd. Shareholding

Promoter

FII

Public

All Data in Percentage (%)

Sep 2024 Dec 2024 Mar 2025 Jun 2025 Sep 2025 Dec 2025
Promoter 62.20 62.20 62.20 62.20 62.10 62.10
FII 0.60 0.60 0.80 1.00 0.90 0.90
Public 1.60 1.60 1.70 1.60 1.60 1.60
Others 35.60 35.60 35.30 35.20 35.40 35.40
Shareholder Shares Holding %
Research 360 logo
Download Our App On: